House panel blames FDA for drug shortages

Share this article:
Darrell Issa
Darrell Issa

A new report from the House Committee on Oversight and Government Reform blames FDA for shortages of generic injectable medications.

Chairman Darrell Issa (R-CA) says a committee investigation learned that FDA regulatory activity has effectively shut down 30% of manufacturing capacity at four of the largest US producers of generic injectable drugs.

Issa says FDA commissioner Margaret Hamburg and the agency have failed to ensure that its enforcement methods avoid “unnecessary shortages.”

The report notes that between 2010 and 2011, there was a 156% increase in FDA Warning Letters. “Warning letters have resulted in companies agreeing to take manufacturing off-line to address FDA criticisms,” it says. “Bedford Laboratories, Hospira Pharmaceuticals, Sandoz Pharmaceuticals, and Teva Pharmaceuticals were producing nearly one billion units of generic injectable products per year. Facilities at these companies are currently operating at about 700 million units per year. This decrease is a massive reduction in the industries' capacity to supply the nation with injectable medications.”
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Headliner: Ipsen head leads continental charge

Headliner: Ipsen head leads continental charge

"When I look at the business, I actually see patients in my mind. I don't see numbers."

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets